101257-32-3 Usage
Description
1-Methylpiperidine-3-ethanol, also known as 2-(1-Methylpiperidin-3-yl)ethan-1-ol (CAS# 101257-32-3), is an organic compound with a unique chemical structure that features a piperidine ring and an ethanol group. It is a versatile reagent in the field of organic synthesis and has potential applications in various industries due to its chemical properties.
Uses
Used in Pharmaceutical Industry:
1-Methylpiperidine-3-ethanol is used as a synthetic intermediate for the preparation of various pharmaceutical compounds. Its unique structure allows for the creation of 3-(ω-hydroxyalkyl)-substituted N-methylpiperdines and N-methyl-2-piperidones, which can be further utilized in the development of drugs targeting a wide range of medical conditions.
Used in Chemical Synthesis:
In the field of chemical synthesis, 1-Methylpiperidine-3-ethanol serves as a valuable building block for the creation of more complex organic molecules. Its reactivity and functional groups make it a useful component in the synthesis of various chemical products, including specialty chemicals and advanced materials.
Used in Research and Development:
Due to its unique chemical properties and potential applications, 1-Methylpiperidine-3-ethanol is also used in research and development settings. Scientists and researchers can leverage its reactivity to explore new synthetic pathways, develop novel compounds, and study its interactions with other molecules for potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 101257-32-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,2,5 and 7 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 101257-32:
(8*1)+(7*0)+(6*1)+(5*2)+(4*5)+(3*7)+(2*3)+(1*2)=73
73 % 10 = 3
So 101257-32-3 is a valid CAS Registry Number.
101257-32-3Relevant articles and documents
CHEMCIAL COMPOUNDS
-
Page/Page column 71-72, (2010/10/20)
The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 and/or CCR5 of a target cell.
